May 8, 2018 / 8:34 PM / in 2 months

BRIEF-Jazz Pharmaceuticals Reports Q1 Adjusted Earnings Per Share $2.98

May 8 (Reuters) - Jazz Pharmaceuticals PLC:

* JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 GAAP EARNINGS PER SHARE $0.75

* Q1 REVENUE $445 MILLION VERSUS I/B/E/S VIEW $434.2 MILLION

* Q1 EARNINGS PER SHARE VIEW $2.78 -- THOMSON REUTERS I/B/E/S

* UPDATED FINANCIAL GUIDANCE FOR 2018.

* SEES FULL YEAR 2018 GAAP NET INCOME PER DILUTED SHARE $6.60-$7.70

* SEES FULL YEAR 2018 NON-GAAP ADJUSTED NET INCOME PER DILUTED SHARE $12.75-$13.25

* SEES FULL YEAR 2018 TOTAL NET PRODUCT SALES $1,865 MILLION -$1,910 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below